July 24, 2024Open Access

In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

To facilitate the detection and management of potential clinical antiviral resistance, in vitro selection of drug-resistant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) against the virus M

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo

Cite This Study

Zhu et al. (Wed,) studied this question.

synapsesocial.com/papers/68e5f2d2b6db643587587583 https://doi.org/https://doi.org/10.1126/sciadv.adl4013

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT12022 · 64 citations
2The CCP4 suite: programs for protein crystallography1994 · 17,323 citations
3Ordered accumulation of mutations in HIV protease confers resistance to ritonavir1996 · 768 citations
4De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report2022 · 308 citations
5A new coronavirus associated with human respiratory disease in China2020 · 12,891 citations

Me gusta

Guardar

Ver artículo completo